Kezar Life Sciences, Inc. (KZR) Total Assets by Year
Kezar Life Sciences, Inc. closed fiscal year 2025 with $76.6M in total assets, $6.6M in total liabilities and $70.1M in shareholder equity. This represents a decrease of 47.0% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Kezar Life Sciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
KZR Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $76.6M-47.0% | $144.7M-34.6% | $221.2M-26.1% | $299.6M+37.5% | $217.9M+43.5% | $151.8M+69.6% | $89.5M-21.9% | $114.7M+111.5% | $54.2M | N/A |
| Total Liabilities | $6.6M-76.3% | $27.8M-17.5% | $33.7M+13.4% | $29.7M+41.0% | $21.1M+93.8% | $10.9M-5.3% | $11.5M+94.9% | $5.9M-92.6% | $79.9M | N/A |
| Total Equity | $70.1M-40.1% | $116.9M-37.7% | $187.6M-30.5% | $269.9M+37.1% | $196.9M+39.7% | $141.0M+80.6% | $78.0M-28.3% | $108.8M+523.5% | -$25.7M-47.4% | -$17.4M |
KZR Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $68.0M-45.7% | $76.6M-47.0% | $97.7M-40.4% | $109.1M-39.3% | $125.3M-37.1% | $144.7M-34.6% | $164.1M-34.2% | $179.9M-31.7% | $199.1M-29.9% | $221.2M-26.1% | $249.3M-18.2% | $263.4M-17.0% |
| Total Liabilities | $2.8M-87.6% | $6.6M-76.3% | $14.8M-50.9% | $17.3M-40.7% | $22.2M-26.1% | $27.8M-17.5% | $30.0M-9.9% | $29.2M-6.0% | $30.0M-5.3% | $33.7M+13.4% | $33.3M+54.4% | $31.1M+54.4% |
| Total Equity | $65.2M-36.7% | $70.1M-40.1% | $83.0M-38.1% | $91.8M-39.1% | $103.1M-39.1% | $116.9M-37.7% | $134.0M-37.9% | $150.7M-35.1% | $169.1M-33.0% | $187.6M-30.5% | $216.0M-23.7% | $232.3M-21.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Kezar Life Sciences, Inc. financials
Frequently Asked Questions
What was Kezar Life Sciences, Inc.'s total assets in fiscal year 2025?
Kezar Life Sciences, Inc. closed fiscal year 2025 with $76.6M in total assets, $6.6M in total liabilities and $70.1M in shareholder equity.
How fast is Kezar Life Sciences, Inc.'s total assets growing?
Kezar Life Sciences, Inc. (KZR) total assets fell by 47.0% year over year, from $144.7M to $76.6M in fiscal year 2025.
What was Kezar Life Sciences, Inc.'s total assets in the most recent quarter?
Kezar Life Sciences, Inc. (KZR) reported $68.0M in total assets in Q1 2026. This represents a decrease of 45.7% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Kezar Life Sciences, Inc. (KZR) reported on that line in every period on record.